Skip to main navigation Skip to search Skip to main content

Ernstig parkinsonisme ten gevolge van metoclopramide bij een patiënte met polyfarmacie

Translated title of the contribution: Severe parkinsonism as a consequence of metoclopramide use in a patient with polypharmacy
  • A. Hoogendam*
  • , J. Hofmeijer
  • , C. J.M. Frijns
  • , M. Heeringa
  • , S. L.N.M. Schouten-Tjin A Tsoi
  • , P. A.F. Jansen
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

74 Downloads (Pure)

Abstract

A 73-year-old woman, with tuberculosis of the large intestine, developed nausea as a side effect of the antituberculosis drugs. The nausea was treated with metoclopramide. Subsequently she developed severe medication-induced parkinsonism. As her symptoms initially mimicked a depressive disorder, drug-induced parkinsonism was only considered at a later stage. Due to drug-induced impaired function of the liver and kidney the patient had received a toxic dose of metoclopramide. Treatment with biperiden and withdrawal of the metoclopramide resulted in a reduction of the complaints within 3 months, after which the anti-tuberculosis medication could be reintroduced. Adjusting the dose of metoclopramide could possibly have prevented this severe side effect.

Translated title of the contributionSevere parkinsonism as a consequence of metoclopramide use in a patient with polypharmacy
Original languageDutch
Pages (from-to)175-177
Number of pages3
JournalNederlands tijdschrift voor geneeskunde
Volume146
Issue number4
Publication statusPublished - 26 Jan 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 22/3 OA procedure

Fingerprint

Dive into the research topics of 'Severe parkinsonism as a consequence of metoclopramide use in a patient with polypharmacy'. Together they form a unique fingerprint.

Cite this